A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections

• Fan Bu ,

  Contributed equally to this work with: Fan Bu, Gang Ye, Kimberly Morsheimer

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Validation, Writing – review & editing

  Affiliations Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America, Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Gang Ye ,

  Contributed equally to this work with: Fan Bu, Gang Ye, Kimberly Morsheimer

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Validation, Writing – review & editing

  Affiliations Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America, Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Kimberly Morsheimer ,

  Contributed equally to this work with: Fan Bu, Gang Ye, Kimberly Morsheimer

  Roles Data curation, Formal analysis, Investigation, Validation, Writing – review & editing

  Affiliations National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America, Department of Virology, Immunology, and Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America

  ⨯
• Hailey Turner-Hubbard,

  Roles Data curation, Investigation, Validation, Writing – review & editing

  Affiliations Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America, Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Brett Eaton,

  Roles Data curation, Formal analysis, Investigation

  Affiliation Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America

  ⨯
• Manu Anantpadma,

  Roles Data curation, Formal analysis, Funding acquisition, Validation, Writing – review & editing

  Affiliation Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America

  ⨯
• Khaggeswar Bheemanapally,

  Roles Data curation, Formal analysis, Investigation, Validation

  Affiliation Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America

  ⨯
• Chalet Tan,

  Roles Data curation, Formal analysis, Investigation, Validation, Writing – review & editing

  Affiliation Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America

  ⨯
• Robert Davey ,

  Roles Conceptualization, Formal analysis, Validation, Writing – review & editing

  * E-mail: lifang@umn.edu; radavey@bu.edu

  Affiliations National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, United States of America, Department of Virology, Immunology, and Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America

  ⨯
• Fang Li

  Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Validation, Writing – original draft

  * E-mail: lifang@umn.edu; radavey@bu.edu

  Affiliations Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America, Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America

  https://orcid.org/0000-0002-1958-366X

  ⨯